Name: Ostomy Dressing Market by Product [Bags/Pouches (Colostomy, Urostomy, Ileostomy), Skin Barrier Sheets, Skin Barrier Rings, Film Dressings], Application (Cancer, Crohn's Disease), End User (Hospitals, Home Care, ASCs), and Region - Global Forecast to 2031
Brand: MarketsandMarkets
SKU: MD10514
Price: 4950 USD
Availability: InStock

報告摘要

The global ostomy dressings market is projected to reach USD 4.73 billion by 2031 from USD 3.80 billion in 2026, at a CAGR of 4.4% during the forecast period. The ostomy dressings market is projected to grow due to a rise in cases of colorectal cancer, inflammatory bowel diseases, and an aging population that requires ongoing care. Increased awareness of peristomal skin disorders, along with higher survival rates, also contribute to sustained industry growth. Additionally, improvements in healthcare infrastructure in developing countries, favorable reimbursement policies, and the availability of home care services are enhancing access to ostomy dressing products. “By product, the skin barrier rings segment is projected to grow at the highest CAGR in the ostomy dressings market during the forecast period.” The market for ostomy products is divided into several segments: ostomy bags/pouches, skin barrier sheets, skin barrier rings, film dressings, and other products. Among these, the skin barrier rings subsegment is expected to grow the fastest during the forecast period. This growth is driven by increasing awareness of peristomal skin issues and the rising demand for effective leakage protection. Skin barrier rings are moldable and adhesive aids used around the stoma site to create a seal between the skin and the ostomy bag. Patients’ preference for home care and convenience is driving a growing demand for user-friendly, custom-fit products. Additionally, advancements in skin-friendly materials and a heightened focus on preventative skincare measures are contributing to the market's expansion. “By end user, the hospitals segment held the second-largest share of the ostomy dressings market in 2025.” The ostomy dressings market is categorized by end users into hospitals, home care settings, ambulatory surgery centers, and other end users. In 2025, the hospitals segment is expected to hold the second-largest market share. This is primarily due to the crucial role hospitals play in both surgeries and post-surgery care. Most ostomy cases, including colostomy, ileostomy, and urostomy, typically occur in hospitals, making them a significant source of demand for ostomy dressings during treatment. Additionally, hospitals are important for educating patients about ostomy care and offering a variety of products for treatment. They employ highly skilled personnel who use advanced products, leading to an increased utilization of ostomy dressings within these facilities. “The Asia Pacific regional segment is expected to grow at the highest CAGR in the ostomy dressings market during the forecast period.” The ostomy dressings market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to experience the highest CAGR due to the increasing burden of cancer in the region, which will lead to a rise in the number of patients requiring ostomy surgery. In 2022, India reported approximately 1.46 million newly diagnosed cancer cases (Indian Journal of Medical Research), while China estimated around 4.82 million cases (GLOBOCAN 2022). Moreover, Japan is projected to reach about 979,300 cases by 2024, according to an article published by the Foundation for the Promotion of Cancer Research. These figures highlight the significant need for surgeries, particularly for colorectal and bladder cancers. Additionally, the Asia Pacific region is benefiting from advancements in healthcare infrastructure, increased healthcare spending, and improved access to surgical facilities. Growing awareness of ostomy care, supportive reimbursement policies, and home care initiatives are also contributing to the adoption of ostomy products. A breakdown of the primary participants (supply side) for the ostomy dressings market referred to in this report is provided below: • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) • By Designation: C-level Executives (45%), Directors (35%), and Others (20%) • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%) Prominent players in the ostomy dressings market: Coloplast A/S (Denmark), ConvaTec Group Plc (UK), Hollister (US), Salts Healthcare (UK), B. Braun SE (Germany), Solventum (US), Welland Medical Limited (UK), ALCARE Co., Ltd. (Japan), Eakin Healthcare Group (Ireland), Marlen Manufacturing & Development (US), Advin Health Care (India), and Nu-Hope Laboratories, Inc. (US), among others Research Coverage The report analyzes the ostomy dressings market and estimates its size and future growth potential across segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help market leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall ostomy dressing market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers:  Analysis of key drivers (rising colorectal and bladder cancer incidence and rising IBD prevalence), restraints (post-surgical complications and quality-of-life concerns), opportunities (rising reimbursement support and awareness initiatives), and challenges (limited awareness and education among patients and caregivers) • Market Penetration: It includes extensive information on products offered by the major players in the global ostomy dressings market. The report includes various segments in products, applications, end users, and regions. • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global ostomy dressings market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global ostomy dressings market. • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global ostomy dressings market.

目錄 Table of Contents

1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.3 STUDY SCOPE 25 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 25 1.3.2 INCLUSIONS & EXCLUSIONS 26 1.3.3 YEARS CONSIDERED 27 1.3.4 CURRENCY CONSIDERED 27 1.4 STAKEHOLDERS 28 2 EXECUTIVE SUMMARY 29 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 29 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 30 2.3 DISRUPTIVE TRENDS SHAPING MARKET 31 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 32 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 33 3 PREMIUM INSIGHTS 34 3.1 OSTOMY DRESSINGS MARKET OVERVIEW 34 3.2 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY END USER 35 3.3 OSTOMY DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36 3.4 OSTOMY DRESSINGS MARKET: REGIONAL MIX 36 3.5 OSTOMY DRESSINGS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 37 4 MARKET OVERVIEW 38 4.1 INTRODUCTION 38 4.2 MARKET DYNAMICS 38 4.2.1 DRIVERS 38 4.2.1.1 Rise in colorectal and bladder cancer incidence accelerates long-term demand for ostomy dressing products 38 4.2.1.2 Rise in IBD prevalence driving sustained demand for ostomy dressings products 39 4.2.2 RESTRAINTS 39 4.2.2.1 Post-surgical complications and quality-of-life concerns are restraining ostomy dressing adoption 39 4.2.3 OPPORTUNITIES 40 4.2.3.1 Increase in reimbursement support and awareness initiatives drive adoption in emerging markets 40 4.2.4 CHALLENGES 40 4.2.4.1 Limited awareness and education among patients and caregivers 40 4.3 UNMET NEEDS AND WHITE SPACES 41 4.3.1 UNMET NEEDS IN OSTOMY DRESSINGS MARKET 41 4.3.2 WHITE SPACE OPPORTUNITIES 41 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 41 4.4.1 INTERCONNECTED MARKETS 41 4.4.2 CROSS-SECTOR OPPORTUNITIES 42 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 42 5 INDUSTRY TRENDS 43 5.1 PORTER’S FIVE FORCES ANALYSIS 43 5.1.1 THREAT OF NEW ENTRANTS 44 5.1.2 THREAT OF SUBSTITUTES 44 5.1.3 BARGAINING POWER OF BUYERS 44 5.1.4 BARGAINING POWER OF SUPPLIERS 44 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 45 5.2 MACROECONOMIC OUTLOOK 45 5.2.1 INTRODUCTION 45 5.2.2 GDP TRENDS AND FORECAST 45 5.2.3 TRENDS IN STOMA CARE INDUSTRY 47 5.2.4 TRENDS IN GLOBAL WOUND CARE INDUSTRY 47 5.3 SUPPLY CHAIN ANALYSIS 47 5.4 VALUE CHAIN ANALYSIS 48 5.5 ECOSYSTEM ANALYSIS 50 5.6 PRICING ANALYSIS 51 5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR VARIOUS PRODUCTS 51 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION 52 5.7 TRADE ANALYSIS 52 5.7.1 IMPORT SCENARIO (HS CODE 300691) 52 5.7.2 EXPORT DATA (HS CODE 300691) 53 5.8 KEY CONFERENCES AND EVENTS, 2026–2027 54 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55 5.10 INVESTMENT AND FUNDING SCENARIO 56 5.11 IMPACT OF 2025 US TARIFFS - OSTOMY DRESSINGS MARKET 56 5.11.1 INTRODUCTION 56 5.11.2 KEY TARIFF RATES 57 5.11.3 PRICE IMPACT ANALYSIS 58 5.11.4 IMPACT ON COUNTRIES/REGIONS 58 5.11.4.1 North America 58 5.11.4.2 Europe 58 5.11.4.3 Asia Pacific 58 5.11.5 END-USE INDUSTRY IMPACT 59 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 60 6.1 KEY EMERGING TECHNOLOGIES 60 6.1.1 ADVANCED SKIN BARRIER TECHNOLOGIES 60 6.1.2 LEAK PREVENTION & FLEXIBLE ADHESIVE SYSTEMS 60 6.2 COMPLEMENTARY TECHNOLOGIES 60 6.2.1 DERMATOLOGY AND SKIN CARE TECHNOLOGIES 60 6.3 TECHNOLOGY/PRODUCT ROADMAP 61 6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 61 6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 61 6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 62 6.4 PATENT ANALYSIS 62 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 63 6.5 FUTURE APPLICATIONS 64 6.5.1 SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT 64 6.5.2 SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS 65 6.6 IMPACT OF AI/GEN AI ON OSTOMY DRESSINGS MARKET 65 6.6.1 TOP USE CASES AND MARKET POTENTIAL 65 6.7 BEST PRACTICES IN OSTOMY DRESSING PROCESSING 66 6.7.1 CASE STUDIES OF AI IMPLEMENTATION IN OSTOMY DRESSINGS MARKET 66 6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 66 6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN OSTOMY DRESSINGS MARKET 66 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 67 7.1 REGIONAL REGULATIONS AND COMPLIANCE 67 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 7.1.2 INDUSTRY STANDARDS 69 7.2 SUSTAINABILITY INITIATIVES 69 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF OSTOMY DRESSINGS MARKET 69 7.2.1.1 Carbon impact reduction 69 7.2.1.2 Eco-applications 70 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 70 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 70 7.5 REIMBURSEMENT ANALYSIS 71 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 72 8.1 DECISION-MAKING PROCESS 72 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 72 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 72 8.2.2 KEY BUYING CRITERIA 73 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 74 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 74 8.5 MARKET PROFITABILITY 74 8.5.1 REVENUE POTENTIAL 75 8.5.2 COST DYNAMICS 75 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 75 9 OSTOMY DRESSINGS MARKET, BY PRODUCT 76 9.1 INTRODUCTION 77 9.2 BAGS/POUCHES 77 9.2.1 COLOSTOMY BAGS/POUCHES 78 9.2.1.1 Rise in colorectal cancer burden to drive sustained demand for colostomy bags 78 9.2.2 ILEOSTOMY BAGS/POUCHES 79 9.2.2.1 Rise in prevalence of inflammatory bowel diseases to fuel growth of ileostomy bags 79 9.2.3 UROSTOMY BAGS/POUCHES 81 9.2.3.1 Increase in bladder cancer incidence to support sustained demand for urostomy bags 81 9.3 SKIN BARRIER SHEETS 82 9.3.1 INCREASE IN FOCUS ON PERISTOMAL SKIN PROTECTION AND COMPLICATION PREVENTION TO FUEL GROWTH OF SKIN BARRIER SHEETS 82 9.4 SKIN BARRIER RINGS 83 9.4.1 RISE IN FOCUS ON LEAKAGE PREVENTION AND SKIN PROTECTION DRIVING GROWTH OF OSTOMY SKIN BARRIER RINGS 83 9.5 FILM DRESSINGS 84 9.5.1 GROWTH IN EMPHASIS ON PREVENTIVE SKIN CARE AND ADHESION SUPPORT TO SUPPORT ADOPTION OF OSTOMY FILM DRESSINGS 84 9.6 OTHER PRODUCTS 85 10 OSTOMY DRESSINGS MARKET, BY APPLICATION 86 10.1 INTRODUCTION 87 10.2 CANCER (COLON, BLADDER) 87 10.2.1 CONTINUOUS USAGE OF RELIABLE, HIGH-PERFORMANCE PRODUCTS ACROSS EXTENDED CANCER SURVIVAL PERIODS TO DRIVE CONSUMPTION VOLUMES 87 10.3 CROHN’S DISEASE 88 10.3.1 LIFELONG MANAGEMENT OF CROHN’S DISEASE WITH POTENTIAL FOR MULTIPLE SURGERIES INCREASES DEPENDENCY ON OSTOMY CARE SOLUTIONS 88 10.4 TRAUMATIC INJURY 90 10.4.1 DEPENDENCY ON OSTOMY DRESSINGS FOR POST-SURGICAL MANAGEMENT DURING RECOVERY OR LONG-TERM CARE TO DRIVE CONSISTENT DEMAND 90 10.5 ULCERATIVE COLITIS 91 10.5.1 CHRONIC NATURE OF UC, COMBINED WITH INCREASING INCIDENCE AND LONG-TERM DISEASE MANAGEMENT, TO DRIVE SUSTAINED DEMAND 91 10.6 OTHER APPLICATIONS 92 11 OSTOMY DRESSINGS MARKET, BY END USER 93 11.1 INTRODUCTION 94 11.2 HOME CARE SETTINGS 95 11.2.1 HOME CARE SETTINGS SEGMENT HELD MAJOR SHARE IN MARKET 95 11.3 HOSPITALS 96 11.3.1 HIGH VOLUME OF OSTOMY SURGERIES IN HOSPITALS TO DRIVE SIGNIFICANT DEMAND 96 11.4 AMBULATORY SURGICAL CENTERS 97 11.4.1 GROWTH IN COST-EFFICIENT OUTPATIENT COLORECTAL PROCEDURES TO DRIVE SEGMENTAL GROWTH 97 11.5 OTHER END USERS 98 12 OSTOMY DRESSINGS MARKET, BY REGION 99 12.1 INTRODUCTION 100 12.2 NORTH AMERICA 101 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 101 12.2.2 US 103 12.2.2.1 US: Largest country-level North American market 103 12.2.3 CANADA 105 12.2.3.1 Rise in cancer burden and aging population to drive demand 105 12.3 EUROPE 107 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 107 12.3.2 GERMANY 110 12.3.2.1 Germany: Largest share in European ostomy dressings market 110 12.3.3 UK 111 12.3.3.1 Established stoma patient base driving demand 111 12.3.4 FRANCE 113 12.3.4.1 High ostomy patient base and cancer incidence to fuel demand 113 12.3.5 ITALY 115 12.3.5.1 Rise in cancer incidence and established stoma patient base to drive ostomy dressing products demand 115 12.3.6 SPAIN 116 12.3.6.1 Increase in urostomy procedures to drive ostomy care demand in Spain 116 12.3.7 REST OF EUROPE 118 12.4 ASIA PACIFIC 120 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 120 12.4.2 CHINA 123 12.4.2.1 China: Largest share in Asia Pacific ostomy dressings market 123 12.4.3 JAPAN 124 12.4.3.1 Rising disease burden, with advanced healthcare infrastructure, strong reimbursement systems, and high adoption of innovative medical products, in Japan 124 12.4.4 INDIA 126 12.4.4.1 Rise in cancer incidence and expanding access to surgical care to support demand 126 12.4.5 AUSTRALIA 128 12.4.5.1 Established patient base and strong healthcare infrastructure, reimbursement support through national programs to aid market growth 128 12.4.6 SOUTH KOREA 129 12.4.6.1 Increase in cancer incidence to aid growth of ostomy dressings market in South Korea 129 12.4.7 REST OF ASIA PACIFIC 131 12.5 LATIN AMERICA 133 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 133 12.5.2 BRAZIL 135 12.5.2.1 Brazil: Largest share in Latin American market 135 12.5.3 MEXICO 137 12.5.3.1 Population prone to cancer and gastrointestinal disorders and aging to contribute to market growth 137 12.5.4 REST OF LATIN AMERICA 139 12.6 MIDDLE EAST & AFRICA 140 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 140 12.6.2 GCC COUNTRIES 143 12.6.2.1 Rise in cancer incidence and strong healthcare infrastructure to aid market growth 143 12.6.3 REST OF MIDDLE EAST & AFRICA 144 13 COMPETITIVE LANDSCAPE 147 13.1 INTRODUCTION 147 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 147 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET 147 13.3 REVENUE ANALYSIS, 2021–2025 148 13.4 MARKET SHARE ANALYSIS, 2025 149 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 151 13.5.1 STARS 151 13.5.2 PERVASIVE PLAYERS 151 13.5.3 EMERGING LEADERS 151 13.5.4 PARTICIPANTS 151 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 153 13.5.5.1 Company footprint 153 13.5.5.2 Regional footprint 154 13.5.5.3 Product Footprint 154 13.5.5.4 Application footprint 155 13.5.5.5 End-user footprint 155 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 156 13.6.1 PROGRESSIVE COMPANIES 156 13.6.2 RESPONSIVE COMPANIES 156 13.6.3 DYNAMIC COMPANIES 156 13.6.4 STARTING BLOCKS 156 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 158 13.6.5.1 Detailed list of key startups/SMEs 158 13.6.5.2 Competitive benchmarking of key startups/SMEs 159 13.7 COMPANY VALUATION & FINANCIAL METRICS 160 13.7.1 FINANCIAL METRICS 160 13.7.2 COMPANY VALUATION 160 13.8 BRAND/PRODUCT COMPARISON 161 13.9 COMPETITIVE SCENARIO 162 13.9.1 PRODUCT LAUNCHES & APPROVALS 162 13.9.2 DEALS 163 13.9.3 EXPANSIONS 164 14 COMPANY PROFILES 165 14.1 KEY PLAYERS 165 14.1.1 COLOPLAST A/S 165 14.1.1.1 Business overview 165 14.1.1.2 Products offered 166 14.1.1.3 Recent developments 170 14.1.1.3.1 Product launches & approvals 170 14.1.1.3.2 Deals 170 14.1.1.3.3 Expansions 170 14.1.1.4 MnM view 171 14.1.1.4.1 Right to win 171 14.1.1.4.2 Strategic choices 171 14.1.1.4.3 Weaknesses & competitive threats 171 14.1.2 CONVATEC GROUP PLC 172 14.1.2.1 Business overview 172 14.1.2.2 Products offered 173 14.1.2.3 Recent developments 176 14.1.2.3.1 Product launches & approvals 176 14.1.2.3.2 Deals 176 14.1.2.3.3 Expansions 176 14.1.2.4 MnM view 177 14.1.2.4.1 Right to win 177 14.1.2.4.2 Strategic choices 177 14.1.2.4.3 Weaknesses & competitive threats 177 14.1.3 B BRAUN SE 178 14.1.3.1 Business overview 178 14.1.3.2 Products offered 179 14.1.3.3 MnM view 181 14.1.3.3.1 Right to win 181 14.1.3.3.2 Strategic choices 181 14.1.3.3.3 Weaknesses & competitive threats 181 14.1.4 HOLLISTER INCORPORATED 182 14.1.4.1 Business overview 182 14.1.4.2 Recent developments 185 14.1.4.2.1 Product launches & approvals 185 14.1.4.2.2 Expansions 185 14.1.4.2.3 Other developments 185 14.1.4.3 MnM view 186 14.1.4.3.1 Right to win 186 14.1.4.3.2 Strategic choices 186 14.1.4.3.3 Weaknesses & competitive threats 186 14.1.5 SOLVENTUM 187 14.1.5.1 Business overview 187 14.1.5.2 Recent developments 189 14.1.5.2.1 Other developments 189 14.1.5.3 MnM view 189 14.1.5.3.1 Right to win 189 14.1.5.3.2 Strategic choices 189 14.1.5.3.3 Weaknesses & competitive threats 189 14.1.6 ADVIN HEALTH CARE 190 14.1.6.1 Business overview 190 14.1.6.2 Recent developments 191 14.1.6.2.1 Expansions 191 14.1.7 SALTS HEALTHCARE 192 14.1.7.1 Business overview 192 14.1.8 WELLAND MEDICAL LIMITED 194 14.1.8.1 Business overview 194 14.1.8.2 Recent developments 195 14.1.8.2.1 Product launches & approvals 195 14.1.8.2.2 Deals 196 14.1.9 ALCARE CO., LTD. 197 14.1.9.1 Business overview 197 14.1.10 EAKIN 199 14.1.10.1 Business overview 199 14.1.10.1.1 Expansions 201 14.1.11 MARLEN MANUFACTURING & DEVELOPMENT COMPANY 202 14.1.11.1 Business overview 202 14.2 OTHER PLAYERS 204 14.2.1 CYMED 204 14.2.2 ADVACARE PHARMA 205 14.2.3 NU-HOPE LABORATORIES, INC. 206 14.2.4 SAFE N SIMPLE LLC 207 14.2.5 TORBOT, A DIVISION OF SAFETEC 208 14.2.6 FOR LIFE PRODUKTIONS 209 14.2.7 FORTIS MEDICAL PRODUCTS 210 14.2.8 ANGIPLAST PRIVATE LIMITED 211 14.2.9 PROWESS CARE 211 14.2.10 TRIO HEALTHCARE LTD 212 14.2.11 AVITR FARMICA PVT LTD. 213 14.2.12 CRIMSON HEALTHCARE PVT. LTD 214 14.2.13 WUJIANG EVERGREEN EX/IM CO., LTD. 215 14.2.14 OSTOFORM 216 15 RESEARCH METHODOLOGY 217 15.1 RESEARCH DATA 217 15.1.1 SECONDARY DATA 217 15.1.1.1 Key data from secondary sources 219 15.1.2 PRIMARY DATA 219 15.1.2.1 Key data from primary sources 221 15.1.2.2 Key industry insights 221 15.2 MARKET SIZE ESTIMATION 222 15.3 DATA TRIANGULATION 227 15.4 MARKET RANKING ANALYSIS 228 15.5 STUDY ASSUMPTIONS 228 15.6 RESEARCH LIMITATIONS 228 15.6.1 METHODOLOGY-RELATED LIMITATIONS 228 15.6.2 SCOPE-RELATED LIMITATIONS 229 15.7 RISK ASSESSMENT 229 16 APPENDIX 230 16.1 DISCUSSION GUIDE 230 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235 16.3 CUSTOMIZATION OPTIONS 237 16.4 RELATED REPORTS 237 16.5 AUTHOR DETAILS 238

圖表清單 List of Tables & Figures

TABLE 1 OSTOMY DRESSINGS MARKET: INCLUSIONS & EXCLUSIONS 26 TABLE 2 STANDARD CURRENCY CONVERSION RATES 28 TABLE 3 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 42 TABLE 4 OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS 44 TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 45 TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD) 51 TABLE 7 AVERAGE PRICING TREND OF OSTOMY DRESSING, BY REGION, 2023–2025 (USD) 52 TABLE 8 IMPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019–2024 (USD THOUSAND) 53 TABLE 9 EXPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019–2024 (USD THOUSAND) 53 TABLE 10 OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 54 TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 57 TABLE 12 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR OSTOMY DRESSING PRODUCTS 58 TABLE 13 SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT 64 TABLE 14 SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS 65 TABLE 15 TOP USE CASES AND MARKET POTENTIAL 65 TABLE 16 OSTOMY DRESSINGS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 66 TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 66 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 22 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 23 GLOBAL STANDARDS IN OSTOMY DRESSINGS MARKET 69 TABLE 24 CERTIFICATIONS, LABELING, ECO-STANDARDS IN OSTOMY DRESSINGS MARKET 70 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR OSTOMY DRESSING PRODUCTS 73 TABLE 26 KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS 73 TABLE 27 OSTOMY DRESSINGS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 74 TABLE 28 OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 77 TABLE 29 OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 78 TABLE 30 COLOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 79 TABLE 31 ILEOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 80 TABLE 32 UROSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 81 TABLE 33 OSTOMY SKIN BARRIER SHEETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 82 TABLE 34 OSTOMY SKIN BARRIER RINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 83 TABLE 35 OSTOMY FILM DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 84 TABLE 36 OTHER OSTOMY DRESSING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 85 TABLE 37 OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 87 TABLE 38 OSTOMY DRESSINGS MARKET IN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 88 TABLE 39 OSTOMY DRESSINGS MARKET IN CROHN’S DISEASE TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 89 TABLE 40 OSTOMY DRESSINGS MARKET IN TRAUMATIC INJURY TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 90 TABLE 41 OSTOMY DRESSINGS MARKET IN ULCERATIVE COLITIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 91 TABLE 42 OSTOMY DRESSINGS MARKET IN OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 92 TABLE 43 OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 94 TABLE 44 OSTOMY DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 95 TABLE 45 OSTOMY DRESSINGS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 96 TABLE 46 OSTOMY DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 47 OSTOMY DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 98 TABLE 48 OSTOMY DRESSINGS MARKET, BY REGION, 2024–2031 (USD MILLION) 101 TABLE 49 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 101 TABLE 50 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 102 TABLE 51 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 102 TABLE 52 NORTH AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 102 TABLE 53 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 103 TABLE 54 NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 103 TABLE 55 US: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 104 TABLE 56 US: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 104 TABLE 57 US: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 104 TABLE 58 US: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 105 TABLE 59 CANADA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 105 TABLE 60 CANADA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 106 TABLE 61 CANADA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 106 TABLE 62 CANADA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 106 TABLE 63 EUROPE: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108 TABLE 64 EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 108 TABLE 65 EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 108 TABLE 66 EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 109 TABLE 67 EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 109 TABLE 68 EUROPE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 109 TABLE 69 GERMANY: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 110 TABLE 70 GERMANY: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 110 TABLE 71 GERMANY: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 111 TABLE 72 GERMANY: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 111 TABLE 73 UK: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 112 TABLE 74 UK: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 112 TABLE 75 UK: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 112 TABLE 76 UK: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 113 TABLE 77 FRANCE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 113 TABLE 78 FRANCE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 114 TABLE 79 FRANCE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 114 TABLE 80 FRANCE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 114 TABLE 81 ITALY: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 115 TABLE 82 ITALY: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 115 TABLE 83 ITALY: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 116 TABLE 84 ITALY: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 116 TABLE 85 SPAIN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 117 TABLE 86 SPAIN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 117 TABLE 87 SPAIN: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 117 TABLE 88 SPAIN: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 118 TABLE 89 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 118 TABLE 90 REST OF EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 119 TABLE 91 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 119 TABLE 92 REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 119 TABLE 93 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 94 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 121 TABLE 95 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 121 TABLE 96 ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 122 TABLE 97 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 122 TABLE 98 ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 122 TABLE 99 CHINA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 123 TABLE 100 CHINA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 123 TABLE 101 CHINA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 124 TABLE 102 CHINA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 124 TABLE 103 JAPAN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 125 TABLE 104 JAPAN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 125 TABLE 105 JAPAN: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 125 TABLE 106 JAPAN: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 126 TABLE 107 INDIA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 126 TABLE 108 INDIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 109 INDIA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 127 TABLE 110 INDIA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 127 TABLE 111 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 128 TABLE 112 AUSTRALIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 128 TABLE 113 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129 TABLE 114 AUSTRALIA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 129 TABLE 115 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 130 TABLE 116 SOUTH KOREA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 130 TABLE 117 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 130 TABLE 118 SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 131 TABLE 119 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 131 TABLE 120 REST OF ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 121 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 132 TABLE 122 REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 132 TABLE 123 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 124 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 134 TABLE 125 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 134 TABLE 126 LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 127 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 135 TABLE 128 LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 135 TABLE 129 BRAZIL: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 136 TABLE 130 BRAZIL: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 131 BRAZIL: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136 TABLE 132 BRAZIL: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 137 TABLE 133 MEXICO: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 137 TABLE 134 MEXICO: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 135 MEXICO: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 138 TABLE 136 MEXICO: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 138 TABLE 137 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 139 TABLE 138 REST OF LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 139 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 140 TABLE 140 REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 140 TABLE 141 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 142 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 141 TABLE 143 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 141 TABLE 144 MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 142 TABLE 145 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 142 TABLE 146 MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 142 TABLE 147 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 143 TABLE 148 GCC COUNTRIES: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 149 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144 TABLE 150 GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 144 TABLE 151 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 145 TABLE 152 REST OF MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION) 145 TABLE 153 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 145 TABLE 154 REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION) 146 TABLE 155 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET 147 TABLE 156 OSTOMY DRESSINGS MARKET: DEGREE OF COMPETITION 150 TABLE 157 OSTOMY DRESSINGS MARKET: REGIONAL FOOTPRINT, 2025 154 TABLE 158 OSTOMY DRESSINGS MARKET: PRODUCT FOOTPRINT, 2025 154 TABLE 159 OSTOMY DRESSINGS MARKET: APPLICATION FOOTPRINT, 2025 155 TABLE 160 OSTOMY DRESSINGS MARKET: END-USER FOOTPRINT, 2025 155 TABLE 161 OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 158 TABLE 162 OSTOMY DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 159 TABLE 163 OSTOMY DRESSINGS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2026 162 TABLE 164 OSTOMY DRESSINGS MARKET: DEALS, JANUARY 2022–MARCH 2026 163 TABLE 165 OSTOMY DRESSINGS MARKET: EXPANSIONS, JANUARY 2022–MARCH 2026 164 TABLE 166 COLOPLAST A/S: COMPANY OVERVIEW 165 TABLE 167 COLOPLAST A/S: PRODUCTS OFFERED 166 TABLE 168 COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS 170 TABLE 169 COLOPLAST A/S: DEALS 170 TABLE 170 COLOPLAST A/S: EXPANSIONS 170 TABLE 171 CONVATEC GROUP PLC: COMPANY OVERVIEW 172 TABLE 172 CONVATEC GROUP PLC: PRODUCTS OFFERED 173 TABLE 173 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS 176 TABLE 174 CONVATEC GROUP PLC: DEALS 176 TABLE 175 CONVATEC GROUP PLC: EXPANSIONS 176 TABLE 176 B BRAUN SE: COMPANY OVERVIEW 178 TABLE 177 B BRAUN SE: PRODUCTS OFFERED 179 TABLE 178 HOLLISTER INCORPORATED: COMPANY OVERVIEW 182 TABLE 179 HOLLISTER INCORPORATED: PRODUCTS OFFERED 182 TABLE 180 HOLLISTER INCORPORATED: PRODUCT LAUNCHES & APPROVALS 185 TABLE 181 HOLLISTER INCORPORATED: EXPANSIONS 185 TABLE 182 HOLLISTER INCORPORATED: OTHER DEVELOPMENTS 185 TABLE 183 SOLVENTUM: COMPANY OVERVIEW 187 TABLE 184 SOLVENTUM: PRODUCTS OFFERED 188 TABLE 185 SOLVENTUM: OTHER DEVELOPMENTS 189 TABLE 186 ADVIN HEALTH CARE: COMPANY OVERVIEW 190 TABLE 187 ADVIN HEALTH CARE: PRODUCTS OFFERED 190 TABLE 188 ADVIN HEALTH CARE: EXPANSIONS 191 TABLE 189 SALTS HEALTHCARE: COMPANY OVERVIEW 192 TABLE 190 SALTS HEALTHCARE: PRODUCTS OFFERED 192 TABLE 191 WELLAND MEDICAL LIMITED: COMPANY OVERVIEW 194 TABLE 192 WELLAND MEDICAL LIMITED.: PRODUCTS OFFERED 194 TABLE 193 WELLAND MEDICAL LIMITED: PRODUCT LAUNCHES & APPROVALS 195 TABLE 194 WELLAND MEDICAL LIMITED: DEALS 196 TABLE 195 ALCARE CO., LTD.: COMPANY OVERVIEW 197 TABLE 196 ALCARE CO., LTD.: PRODUCTS OFFERED 197 TABLE 197 EAKIN: COMPANY OVERVIEW 199 TABLE 198 EAKIN: PRODUCTS OFFERED 199 TABLE 199 EAKIN: EXPANSIONS 201 TABLE 200 MARLEN MANUFACTURING & DEVELOPMENT COMPANY: COMPANY OVERVIEW 202 TABLE 201 MARLEN MANUFACTURING & DEVELOPMENT COMPANY: PRODUCTS OFFERED 202 TABLE 202 CYMED: COMPANY OVERVIEW 204 TABLE 203 ADVACARE PHARMA: COMPANY OVERVIEW 205 TABLE 204 NU-HOPE LABORATORIES, INC.: COMPANY OVERVIEW 206 TABLE 205 SAFE N SIMPLE LLC: COMPANY OVERVIEW 207 TABLE 206 TORBOT, A DIVISION OF SAFETEC: COMPANY OVERVIEW 208 TABLE 207 FOR LIFE PRODUKTIONS: COMPANY OVERVIEW 209 TABLE 208 FORTIS MEDICAL PRODUCTS: COMPANY OVERVIEW 210 TABLE 209 ANGIPLAST PRIVATE LIMITED: COMPANY OVERVIEW 211 TABLE 210 PROWESS CARE: COMPANY OVERVIEW 211 TABLE 211 TRIO HEALTHCARE LTD: COMPANY OVERVIEW 212 TABLE 212 AVITR FARMICA PVT LTD.: COMPANY OVERVIEW 213 TABLE 213 CRIMSON HEALTHCARE PVT. LTD: COMPANY OVERVIEW 214 TABLE 214 WUJIANG EVERGREEN EX/IM CO., LTD.: COMPANY OVERVIEW 215 TABLE 215 OSTOFORM: COMPANY OVERVIEW 216 TABLE 216 OSTOMY DRESSINGS MARKET: STUDY ASSUMPTIONS 228 TABLE 217 OSTOMY DRESSINGS MARKET: RISK ASSESSMENT ANALYSIS 229 FIGURE 1 OSTOMY DRESSINGS MARKET: SEGMENTS CONSIDERED 25 FIGURE 2 YEARS CONSIDERED 27 FIGURE 3 KEY INSIGHTS AND MARKET HIGHLIGHTS 29 FIGURE 4 OSTOMY DRESSINGS MARKET, 2026–2031 (USD MILLION) 29 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET 30 FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF OSTOMY DRESSINGS MARKET 31 FIGURE 7 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN OSTOMY DRESSINGS MARKET, 2025 32 FIGURE 8 EUROPE TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD 33 FIGURE 9 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 34 FIGURE 10 HOME CARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN OSTOMY DRESSINGS MARKET IN 2025 35 FIGURE 11 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 36 FIGURE 12 EUROPE ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 36 FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 37 FIGURE 14 OSTOMY DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38 FIGURE 15 OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS 43 FIGURE 16 OSTOMY DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS 48 FIGURE 17 OSTOMY DRESSINGS MARKET: VALUE CHAIN ANALYSIS 49 FIGURE 18 OSTOMY DRESSINGS MARKET: ECOSYSTEM ANALYSIS 50 FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55 FIGURE 20 OSTOMY DRESSINGS MARKET: INVESTMENT & FUNDING SCENARIO 56 FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2015–APRIL 2026 63 FIGURE 22 TOP APPLICANT COUNTRIES/REGIONS FOR OSTOMY PRODUCTS, JANUARY 2015− OCTOBER 2025 (NUMBER OF PATENTS) 64 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR OSTOMY DRESSING PRODUCTS 72 FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS 73 FIGURE 25 OSTOMY DRESSINGS MARKET: GEOGRAPHIC SNAPSHOT 100 FIGURE 26 EUROPE: OSTOMY DRESSINGS MARKET SNAPSHOT 107 FIGURE 27 ASIA PACIFIC: OSTOMY DRESSINGS MARKET SNAPSHOT 120 FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN OSTOMY DRESSINGS MARKET, 2021–2025 (USD MILLION) 148 FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OSTOMY DRESSINGS MARKET (2025) 149 FIGURE 30 OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 152 FIGURE 31 OSTOMY DRESSINGS MARKET: COMPANY FOOTPRINT, 2025 153 FIGURE 32 OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 157 FIGURE 33 EV/EBITDA OF KEY VENDORS, 2026 160 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 160 FIGURE 35 OSTOMY DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 161 FIGURE 36 COLOPLAST A/S: COMPANY SNAPSHOT, 2025 166 FIGURE 37 CONVATEC GROUP PLC: COMPANY SNAPSHOT, 2025 173 FIGURE 38 B BRAUN SE: COMPANY SNAPSHOT, 2024 179 FIGURE 39 SOLVENTUM: COMPANY SNAPSHOT, 2025 188 FIGURE 40 RESEARCH DESIGN 217 FIGURE 41 PRIMARY SOURCES 220 FIGURE 42 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 222 FIGURE 43 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 223 FIGURE 44 TOP-DOWN APPROACH 223 FIGURE 45 BOTTOM-UP APPROACH 224 FIGURE 46 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2026–2031 225 FIGURE 47 OSTOMY DRESSINGS MARKET: CAGR PROJECTIONS 226 FIGURE 48 DATA TRIANGULATION METHODOLOGY 227

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Ostomy Dressing Market by Product [Bags/Pouches (Colostomy, Urostomy, Ileostomy), Skin Barrier Sheets, Skin Barrier Rings, Film Dressings], Application (Cancer, Crohn's Disease), End User (Hospitals, Home Care, ASCs), and Region - Global Forecast to 2031

授權報價

報告摘要

同分類最新報告（醫療器材）